Keywords: busy, period, gw, zyban, approved, europe, stroke

Busy period for GW as Zyban approved in Europe and stroke compound fails

Article | 04 May 2000

Print This

During a turbulent week for the firm, Glaxo Wellcome said it hadreceived European approval for the use of Zyban (bupropion ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in